The business can plausibly compound far faster than the stock because Rocket Lab has real shots on goal across launch, defense spacecraft, components, and mission operations. The bottleneck is not demand but proving
Neutron, converting
backlog at scale, and holding trust premiums. Even with strong execution, today’s valuation leaves limited room for multiple expansion, so most upside must come from growing into the price.